How Could a New Longevity Medicine Create $200B Per Year in Revenue? Dr. Greg Bailey and I asked top VC Alex Colville from age1
Longevity for Investors with Dr. Greg Bailey and Jess Larsen
00:00
How early investments scaled into exits and value
Alex outlines Loyal's funding progression from accelerator money to seed and Series A, and notes Laura's initial investment returned 20x.
Transcript
Play full episode
